SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-006961
Filing Date
2023-04-27
Accepted
2023-04-27 08:00:17
Documents
5
Period of Report
2023-06-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A vygr-20230606xdef14a.htm DEF 14A 930260
2 GRAPHIC vygr-20230606xdef14a_a007.jpg GRAPHIC 48217
3 GRAPHIC vygr-20230606xdef14a_a008.jpg GRAPHIC 47162
4 GRAPHIC vygr-20230606xdef14a_bg001.jpg GRAPHIC 135989
5 GRAPHIC vygr-20230606xdef14a_bg002.jpg GRAPHIC 116337
  Complete submission text file 0001558370-23-006961.txt   1410678
Mailing Address 64 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 64 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37625 | Film No.: 23851992
SIC: 2836 Biological Products, (No Diagnostic Substances)